Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:1377-1383
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, Y.
Right arrow Articles by Katagiri, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, Y.
Right arrow Articles by Katagiri, T.

CLINICAL STUDIES

Effects of nicorandil, a potassium channel opener, on idiopathic ventricular tachycardia

Youichi Kobayashi, MDa, Akira Miyata, MDa, Kaoru Tanno, MDa, Shuji Kikushima, MDa, Takao Baba, MDa and Takashi Katagiri, MDa

a Third Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan

Manuscript received October 20, 1997; revised manuscript received June 15, 1998, accepted July 2, 1998.

Address for correspondence: Dr. Youichi Kobayashi, Third Department of Internal Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, Japan 142-8666

Objectives. We assessed the effects of the adenosine triphosphate (ATP)–sensitive potassium channel opener, nicorandil, on ATP- and verapamil-responsive ventricular tachycardias (VTs).

Background. Adenosine- or ATP-sensitive VTs are thought to be due to a nonreentrant mechanism, presumably delayed afterdepolarization. We suggest that this potassium channel opener may suppress ATP- and verapamil-sensitive VTs.

Methods. The subjects included 13 patients with idiopathic VTs, 7 of whom had sustained VT and 6 of whom had nonsustained VT. We evaluated the effects of ATP, nicorandil and verapamil on VTs.

Results. Sustained VT: Verapamil had preventive effects on seven VTs. Four VTs were terminated by ATP, and of these, nicorandil terminated two and prevented exercise-induced VT in the two others. Three ATP-insensitive VTs, which were determined to be due to a reentry by an electrophysiologic study, were not terminated by nicorandil. Nonsustained VT: All six VTs were inhibited by ATP, and five of these were suppressed by nicorandil. Verapamil inhibited four of the five VTs. QT intervals and the corrected QT intervals were significantly shortened by nicorandil.

Conclusions. Nicorandil suppresses ATP- and verapamil-responsive VTs. One of the mechanisms of suppression by nicorandil might be related to a reduction of calcium in the myocardium, because it reduces the action potential duration.

Abbreviations and Acronyms
  APD = action potential duration
  ATP = adenosine triphosphate
  LBBB = left bundle branch block
  LV = left ventricular
  QTc = corrected QT interval
  RBBB = right bundle branch block
  RV = right ventricular
  VPC = ventricular premature contraction
  VT = ventricular tachycardia




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
H. Ueda, T. Hayashi, K. Tsumura, K. Yoshimaru, Y. Nakayama, and J. Yoshikawa
Intravenous Nicorandil Can Reduce QT Dispersion and Prevent Bradyarrhythmia During Percutaneous Transluminal Coronary Angioplasty of the Right Coronary Artery
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 179 - 184.
[Abstract] [PDF]


Home page
Emerg. Med. J.Home page
J P Greenwood, I Malik, P Jennings, and R N Stevenson
Haemodynamic and electrocardiographic consequences of severe nicorandil toxicity
Emerg. Med. J., January 1, 2003; 20(1): 98 - 100.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement